
Blog|Articles|February 8, 2022
Interactive Case Study in Migraine Prevention
Advertisement
We invite you to navigate through the treatment journey of a patient living with migraine.
Explore the individual patient outcomes and learn about the efficacy and safety of a monoclonal antibody for the preventive treatment of migraine.
This program is intended for US audiences only. This program is not approved for continuing medical education (CME) credit. ©2022. Lundbeck. All rights reserved. MIG-D-100153.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Del-Desiran Fails to Meet Primary Endpoint in Phase 3 HARBOR Trial of Myotonic Dystrophy 1
2
NeuroVoices: Jacqueline Becker, PhD, on Brain Fog, Alzheimer Risk, and Treatment Advances in Long COVID
3
Investigational Zorevunersen Linked to Adaptive Gains in Dravet Syndrome
4
Excessive Daytime Sleepiness Associated With Cognitive Deficits and Abnormal Brain Network Topology in Obstructive Sleep Apnea
5

















